[go: up one dir, main page]

ITRM990426A0 - Impiego di inibitori della sostanza p per il trattamento degli adenocarcinomi. - Google Patents

Impiego di inibitori della sostanza p per il trattamento degli adenocarcinomi.

Info

Publication number
ITRM990426A0
ITRM990426A0 IT1999RM000426A ITRM990426A ITRM990426A0 IT RM990426 A0 ITRM990426 A0 IT RM990426A0 IT 1999RM000426 A IT1999RM000426 A IT 1999RM000426A IT RM990426 A ITRM990426 A IT RM990426A IT RM990426 A0 ITRM990426 A0 IT RM990426A0
Authority
IT
Italy
Prior art keywords
adenocarcinomas
inhibitors
substance
treatment
Prior art date
Application number
IT1999RM000426A
Other languages
English (en)
Inventor
Maurizio Massi
Pierluigi Pompei
Massimo Nabissi
Pier Luigi Sparapani
Original Assignee
Innova Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Innova Ltd filed Critical Innova Ltd
Priority to IT1999RM000426A priority Critical patent/IT1306165B1/it
Publication of ITRM990426A0 publication Critical patent/ITRM990426A0/it
Priority to EP00953011A priority patent/EP1206259A2/en
Priority to US10/030,305 priority patent/US6576638B1/en
Priority to CA002373960A priority patent/CA2373960A1/en
Priority to JP2001507420A priority patent/JP2003503429A/ja
Priority to PCT/EP2000/006309 priority patent/WO2001001922A2/en
Priority to AU65616/00A priority patent/AU6561600A/en
Publication of ITRM990426A1 publication Critical patent/ITRM990426A1/it
Application granted granted Critical
Publication of IT1306165B1 publication Critical patent/IT1306165B1/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
IT1999RM000426A 1999-07-05 1999-07-05 Impiego di inibitori della sostanza p per il trattamento degliadenocarcinomi. IT1306165B1 (it)

Priority Applications (7)

Application Number Priority Date Filing Date Title
IT1999RM000426A IT1306165B1 (it) 1999-07-05 1999-07-05 Impiego di inibitori della sostanza p per il trattamento degliadenocarcinomi.
EP00953011A EP1206259A2 (en) 1999-07-05 2000-07-05 Use of substance p antagonists for the treatment of adenocarcinoma
US10/030,305 US6576638B1 (en) 1999-07-05 2000-07-05 Use of substance P antagonists in the treatment of the adenocarcinomas
CA002373960A CA2373960A1 (en) 1999-07-05 2000-07-05 Use of substance p antagonists for the treatment of adenocarcinoma
JP2001507420A JP2003503429A (ja) 1999-07-05 2000-07-05 腺ガンの治療におけるサブスタンスｐ拮抗薬の使用方法
PCT/EP2000/006309 WO2001001922A2 (en) 1999-07-05 2000-07-05 Use of substance p antagonists for the treatment of adenocarcinoma
AU65616/00A AU6561600A (en) 1999-07-05 2000-07-05 Use of substance p antagonists in the treatment of the adenocarcinomas

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT1999RM000426A IT1306165B1 (it) 1999-07-05 1999-07-05 Impiego di inibitori della sostanza p per il trattamento degliadenocarcinomi.

Publications (3)

Publication Number Publication Date
ITRM990426A0 true ITRM990426A0 (it) 1999-07-05
ITRM990426A1 ITRM990426A1 (it) 2001-01-05
IT1306165B1 IT1306165B1 (it) 2001-05-30

Family

ID=11406865

Family Applications (1)

Application Number Title Priority Date Filing Date
IT1999RM000426A IT1306165B1 (it) 1999-07-05 1999-07-05 Impiego di inibitori della sostanza p per il trattamento degliadenocarcinomi.

Country Status (7)

Country Link
US (1) US6576638B1 (it)
EP (1) EP1206259A2 (it)
JP (1) JP2003503429A (it)
AU (1) AU6561600A (it)
CA (1) CA2373960A1 (it)
IT (1) IT1306165B1 (it)
WO (1) WO2001001922A2 (it)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002259147A1 (en) * 2001-05-08 2002-11-18 Schering Corporation Use of neurokinin receptor antagonists to treat androgen-dependent diseases
WO2004087165A1 (ja) * 2003-03-28 2004-10-14 Sankyo Company Limited 前立腺肥大症治療薬
ES2246687B2 (es) * 2004-02-11 2006-11-16 Miguel Muñoz Saez Utilizacion de antagonistas no peptidicos de receptores nk1 para la produccion de apoptosis en celulas tumorales.
US20080045610A1 (en) * 2004-09-23 2008-02-21 Alexander Michalow Methods for regulating neurotransmitter systems by inducing counteradaptations
AU2005286733B2 (en) * 2004-09-23 2009-11-05 Alexander Michalow Methods for regulating neurotransmitter systems by inducing counteradaptations
KR20090035279A (ko) * 2007-10-05 2009-04-09 경희대학교 산학협력단 위장관 손상 예방 및 치료용 조성물
EP2281575B9 (en) 2008-04-09 2014-02-12 Universidad de Barcelona Antibodies for treating cancer
ES2376564B1 (es) * 2010-08-12 2013-01-24 Manuel Vicente Salinas Martín Utilización de anticuerpos contra los receptores nk1, nk2 y/o nk3, para producir apoptosis en las células tumorales y modificar el estroma, la inmunidad y la vascularización intra y peritumorales, como tratamiento del cáncer.
CN102188424B (zh) * 2011-03-23 2013-03-27 浙江理工大学 Sr140333的抗血癌作用
WO2013087964A1 (es) 2011-12-13 2013-06-20 Servicio Andaluz De Salud Uso de agentes modificadores del ambiente peritumoral para el tratamiento del cáncer
ES2493693B1 (es) 2013-02-11 2015-07-07 Servicio Andaluz De Salud Método para predecir o pronosticar la respuesta de un sujeto humano que padece un cáncer al tratamiento con un antagonista del receptor NK1
ES2541870B1 (es) 2013-12-27 2016-05-12 Servicio Andaluz De Salud Uso de antagonistas no peptídicos de NK1 en una determinada dosis para el tratamiento del cáncer

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0655055T3 (da) 1992-08-13 2001-01-02 Warner Lambert Co Tachykininantagonister
EP0659409A3 (en) * 1993-11-23 1995-08-09 Pfizer Substance P antagonists for the inhibition of angiogenesis.
CA2189501A1 (en) 1995-11-06 1997-05-07 Harry R. Howard Nk-1 receptor antagonists for the treatment of cancer
EP0835662B1 (en) * 1996-10-08 2001-11-14 National Institute of Immunology A drug for the treatment of cancer

Also Published As

Publication number Publication date
EP1206259A2 (en) 2002-05-22
WO2001001922A2 (en) 2001-01-11
CA2373960A1 (en) 2001-01-11
ITRM990426A1 (it) 2001-01-05
WO2001001922A3 (en) 2001-05-10
JP2003503429A (ja) 2003-01-28
US6576638B1 (en) 2003-06-10
AU6561600A (en) 2001-01-22
IT1306165B1 (it) 2001-05-30

Similar Documents

Publication Publication Date Title
ATE320257T1 (de) (s,s)-reboxetine zur behandlung chronischer schmerzen
ITMI991608A0 (it) Sonda elettrochirurgica per il trattamento di tumori mediante radiofre quenza
IS6195A (is) Notkun á mótefnum gegn CD20 til meðhöndlunar á þegahöfnunarveiki
NO20012170D0 (no) Selvstendig, transportabel blodbehandlingsinnretning
IS2494B (is) Notkun á morfólínóli til meðhöndlunar á kynferðislegri vanvirkni
NO20001870L (no) Ny fremgangsmÕte for behandling
NO20022087L (no) Fremgangsmåte for behandling av diabetes
EE200200571A (et) Hüdroksüfenüülpiperidiin-4-ülideenmetüülbensamiidi derivaadid valu raviks
ITUD990204A0 (it) Procedimento per la determinazione della velocita' di sedimentazione d el sangue e di altri parametri ad essa correlati, e relativo apparato
ITMI991658A0 (it) Procedimento per la preparazione di epossidi
ITRM990426A0 (it) Impiego di inibitori della sostanza p per il trattamento degli adenocarcinomi.
IT1303677B1 (it) Dispositivo per il trattamento termico di pezzi.
EE200200577A (et) Kinolinüülpiperidiin-4-ülideenmetüülbensamiidi derivaadid valu raviks
EE200200511A (et) Hüdroksüfenüülpiperasinüülmetüülbensamiidi derivaadid valu raviks
IT1306193B1 (it) Uso degli ultrasuoni per il trattamento della sintomatologia dadecompressione.
IT1306822B1 (it) Calzoncino per il trattamento topico della cellulite.
IT1316554B1 (it) Dispositivo per il trattamento di rifiuti umidi.
IT244813Y1 (it) Dispositivo per il supporto di apparecchi portatili .
ID24439A (id) Penggunaan tiazolidindion untuk pengobatan hiperglikemia
ITRA980011A1 (it) Bracciale atto al supporto di testatori elettrici portatili.
ITMI20021205A0 (it) Uso di proteine per il trattamento della leishmaniosi
ITMI992459A0 (it) Procedimento per la preparazione di marbofloxacina
IT1311582B1 (it) Ortesi ortopedica per il trattamento di epicondiliti.
ITRM990762A0 (it) Procedimento per la preparazione di filati ondee o compensina.
ITMI20000147A0 (it) Procedimeto per il trattamento di fanghi